| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.0M | -17.2% |
| Cost of Revenue | $2.8M | +3.8% |
| R&D Expense | $5.9M | +10.1% |
| SG&A Expense | $4.3M | +59.3% |
| Operating Income | -$3.7M | -804.3% |
| Pre-tax Income | -$3.6M | -368.6% |
| Income Tax | -$172K | -1825.1% |
| Net Income | -$3.4M | -357.7% |
| EPS (Basic) | -$0.35 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.7M | -31.9% |
| Accounts Receivable | $122K | -20.3% |
| Current Assets | $15.4M | -30.1% |
| Total Assets | $25.4M | -11.9% |
| Current Liabilities | $3.7M | -0.3% |
| Long-term Debt | $77K | -51.6% |
| Total Liabilities | $4.5M | +16.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.0M | -333.6% |
| Investing Cash Flow | -$2.9M | -442.6% |
| Financing Cash Flow | -$998K | -107.2% |
| -305.9% |
| EPS (Diluted) | -$0.35 | -305.9% |
| Stockholders' Equity |
| $21.0M |
| -16.3% |